The Global BiodegradableStents Market, by Product Type (Coronary Stents and Peripheral Stents), byMaterial Type (Polymer-based Stents and Metallic Stents), by End User(Hospitals, Specialty Clinics, and Ambulatory Surgical Centers) and by Region(North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)is estimated to be valued at US$ 278.6 million in 2018, and is projected toexhibit a CAGR of 15.6% over the forecast period (2018 – 2026).
Biodegradable stents are fully degradable meshlike network used for the treatment of blockage in arteries or guts or biliaryducts. According to Transcatheter Cardiovascular Therapeutics (TCT) andAmerican College of Cardiology (ACC) the adoption of stents is expected toshift from conventional metallic stents to bioresorbable stents, boosting thebiodegradable stents market growth. Biodegradable stents market is expected togain trajectory growth, owing to increasing number of approved products inmarket. For instance in 2016, Abbott Laboratories received approval for Absorbbioresorbable heart stent in Japan indicated for treatment of coronary arterydisease.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1917
In same year, Biotronik receivedCE approval for Magmaris, a bioresorbable scaffold. The product offers easierdelivery and more strength resisting inward forces once deployed. In 2015,Boston Scientific received FDA approval for Synergy, first bioresorbable stentto unblock clogged arteries via drug elution. In June 2018, REVA medical, Inc.,received CE approval for Fantom Encore Product line, which comprises of thirdgeneration coronary bioresorbable scaffold. Furthermore, company is alsoplanning to expand its presence in Europe, Middle East, and South America viadistribution partnership. In same month, AMG International received CE approvalfor Archimedes, a biodegradable stent for treatment of obstructive biliary andpancreatic disorders. Such recent product approval are expected to boost themarket growth in near future.
Browse Market Data 32 Tables and30 Figures spread through 150 Pages and in-depth TOC on " Biodegradable StentsMarket, by Product Type (Coronary Stents and Peripheral Stents), by MaterialType (Polymer-based Stents and Metallic Stents), by End User (Hospitals,Specialty Clinics and Ambulatory Surgical Centers) and by Region - GlobalForecast to 2026”
As of 2017, Abbott was the onlycompany which has approval for completely bioresorbable stents. This offerswide opportunity for the market players as well as new entrant to come up withnew fully degradable biodegradable stents to surpass the market. For instance,according to article published in Springer Healthcare, 2013, REVA and ABSORBare the ongoing clinical trials of completely biodegradable stents.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/biodegradable-stents-market-1917
Key Takeaways of theBiodegradable Stents Market:
The global biodegradable stentsmarket is expected to expand at a CAGR of XX% during the forecast period (2018– 2026), owing to increasing product launches
Coronary stents segment isexpected to dominate product type, owing to increasing cases of arteriesblockage
Polymer-based stents holddominant position in material segment due to more number of product underpolymer-based segment and its rising preference amongst medical professionals
Some of the major playersoperating in global biodegradable stents market include Boston ScientificCorporation, Abbott, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir MedicalCorporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc.,and Arterial Remodeling Technologies SA
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1917
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollar opportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
